FDA approval of Alnylam drug is first ever for RNAi-based therapy - STAT

FDA approval of Alnylam drug is first ever for RNAi-based therapy - STAT

FDA approves first-ever RNAi-based therapy

By KATE SHERIDAN @sheridan_kate

AUGUST 10, 2018

FDA approves first-ever RNAi-based therapy

By KATE SHERIDAN

KRISTOFFER TRIPPLAAR/SIPA USA/AP

The FDA approved the Alnylam drug Onpattro, the first-ever therapy based on the technique known as RNA interference.

READ MORE